due emerge new variant pathogen microorgan treatment immune infect disease become great challenge past year context vaccine develop remark effort made develop vaccine also improv efficacy exist specify date develop protein subunit kill pathogen whilst sever base liveattenu organ carry risk regain pathogen certain immunocompromis conduit avoid riskfre effect conduct ade delivery system consider immer need obtain desire humor cellmedi immune last use nanoparticles receive attend strategy target achieve immune response cellular level nanocarri protect antigen premature proteolyt degrade facility antigen uptake process present cell control release safe human compose lipid protein metal poly already use attain attribute physicochem property nanoparticles play import role determine review article focus applied nanocarrierbas formal function accomplish office order induce host 